Sort
34,240 grants matching “atherosclerosis”
Contribution of Longitudinal Neighborhood Determinants to Cognitive Health and Dementia Disparities within a Multi-Ethnic Cohort
$694,463Jana Ariel Hirsch · Drexel University · R01 · FY2025 · AG
Accelerated non-atherosclerotic brain arterial aging relationship to Alzheimer's disease
$694,460Jose Gutierrez · Columbia University Health Sciences · R01 · FY2022 · AG
Fatty Acids and Heart Failure in the Physicians' Health Study
$694,451Luc Djousse · Brigham And Women'S Hospital · R01 · FY2010 · HL
Human Studies on Blood Levels of Glycated CD59 as a Biomarker in Diabetes
$694,341Jose A Halperin · Brigham And Women'S Hospital · R01 · FY2017 · DK
Epidemiology: Oxidative Stress and Early Atherosclerosis
$694,309David R Jacobs · University Of Minnesota · R01 · FY2013 · HL
Novel Targets for Reducing Atherosclerosis in Type 1 Diabetes
$694,247Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2025 · HL
Cholesterol Regulation of Endothelial K+ Channels
$694,203Irena Levitan · University Of Illinois At Chicago · R01 · FY2021 · HL
Multi-Scale Biology of Atherosclerosis in the Cellular Adhesion Pathway
$694,139Suzette Janine Bielinski · Mayo Clinic Rochester · R01 · FY2013 · HL
A hypercholesterolemia-induced immunometabolite in atherosclerosis
$694,138Prediman Krishan Shah · Cedars-Sinai Medical Center · R01 · FY2022 · HL
Longitudinal Study of Predictors and Consequences of Chronic Kidney Disease
$693,992Brad C Astor · Johns Hopkins University · R01 · FY2009 · DK
Novel protein biomarkers of youth-onset type 2 diabetes
$693,964Zsu-Zsu Chen · Beth Israel Deaconess Medical Center · R01 · FY2025 · HL
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
$693,855Connie Meeyoung Rhee · University Of California-Irvine · R01 · FY2019 · DK
Managing Atherosclerosis by Modulating HDL Function
$693,767M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2020 · HL
Managing Atherosclerosis by Modulating HDL Function
$693,767M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2021 · HL
Managing Atherosclerosis by Modulating HDL Function
$693,767M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2019 · HL
ACE Inhibition and Novel Cardiovascular Risk Factors
$693,661Wake Forest University Health Sciences · R01 · FY2002 · HL
Comprehensive Mapping of a Blood Pressure QTL on Chromosome 17
$693,640Kari E North · Univ Of North Carolina Chapel Hill · R01 · FY2008 · HL
Platelets in Cardiovascular Biology and Pathology
$693,570Denisa D Wagner · Massachusetts Institute Of Technology · P01 · FY2009 · HL
Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain
$693,555Andrew Lim · Sunnybrook Research Institute · R01 · FY2020 · AG
Lipid raft therapy â a novel therapeutic approach for HIV-associated cardiometabolic co-morbidities
$693,497Michael Ilya Bukrinsky · George Washington University · R01 · FY2021 · HL
PROTECTING THE BRAIN BY PREVENTING EMBOLIC INJURY
$693,416Wake Forest University Health Sciences · R01 · FY2001 · NS
Inflammasome activation in an SIV-ART model of chronic drug abuse
$693,386Rebecca Terilli Veenhuis · Johns Hopkins University · R01 · FY2023 · DA
Personalized lesion modification optimizes atherosclerosis intervention
$693,340Elazer R Edelman · Massachusetts Institute Of Technology · R01 · FY2023 · HL
Contribution of Longitudinal Neighborhood Determinants to Cognitive Health and Dementia Disparities within a Multi-Ethnic Cohort
$693,256Jana Ariel Hirsch · Drexel University · R01 · FY2024 · AG
The Role of Altered Luminal Dynamics in OSA-Induced Atherosclerosis
$693,249Amir Zarrinpar · University Of California, San Diego · R01 · FY2023 · HL